Merck CEO Robert Davis joins 'Squawk Box' to discuss the company's quarterly earnings results, which topped expectations as the company saw strong sales from its top-selling cancer drug Keytruda ...
Merck CEO Kenneth Frazier is sticking around. The New Jersey-based pharmaceutical giant said Wednesday that its board of directors had overturned a policy requiring CEOs to retire when they turn ...
Guindo brings over 25 years of pharmaceutical industry experience and has held various senior executive roles at Merck, including in global strategy and commercial operations. John Evans ...
Merck & Co Inc (MRK) stock saw a modest uptick, ending the day at $103.55 which represents a slight increase of $2.18 or 2.15% from the prior close of $101.37. The stock opened at $101.49 and touched ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, has ranked No. 1 on Newsweek’s annual list of America’s Most Responsible Companies for the second year in a row.